Trials / Completed
CompletedNCT01625481
Seal-V Safety and Performance Study
Prospective, Single Arm, Open Label, Non-randomized Study to Evaluate The Safety and Performance of The Seal-V System
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 23 (actual)
- Sponsor
- Sealantis Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to further assess the safety and performance of Seal-V as an adjunct to standard surgical procedure for achieving hemostasis in patients undergoing peripheral vascular reconstruction surgeries using synthetic grafts.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Seal-V | Seal-V is applied adjunctively to cover the suture lines. |
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2013-12-01
- Completion
- 2014-03-01
- First posted
- 2012-06-21
- Last updated
- 2014-05-28
Locations
3 sites across 1 country: Israel
Source: ClinicalTrials.gov record NCT01625481. Inclusion in this directory is not an endorsement.